CompletedPhase 3ACTRN12605000600640

The effect of parecoxib on post craniotomy analgesia.

A prospective randomised controlled, double-blind study of Parecoxib versus placebo for postoperative analgesia following craniotomy surgery.

Sponsor

Department of Anaesthesia, St Vincent's Hospital Melbourne

Enrollment

82 participants

Start Date

Oct 6, 2005

Study Type

Interventional

Conditions

Postoperative analgesia for craniotomy surgery.

Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This study tests whether parecoxib (a pain relief medication) can improve pain management after brain surgery (craniotomy). It is open to adults aged 18 and older who are scheduled for craniotomy. Participants would receive either parecoxib or standard pain treatment and report their pain levels after the procedure.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

This prospective randomised controlled, double-blind study has been designed to examine if a single dose of Parecoxib 40mg decreases postoperative pain and morphine requirements for 24 hours following

Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12605000600640